Dana-Farber - Harvard Cancer Center LAO
Boston, Massachusetts 02115
We've found
1 trials
at this facility
Oncology Clinical Trial
Updated: 12/9/2015
Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast Cancer
Status: Upcoming,
Phase
I
Updated: 12/9/2015
Click here to add this to my saved trials
